IP Library Granted Patent US 9,060,784
Granted Patent B2
US 9,060,784 · App. 14/075,949 · Granted Jun 23, 2015

Hepatic denervation systems

Inventors: Jonathan Allen Coe (Menlo Park, CA); Bobak Robert Azamian (Newport Coast, CA); Scott Bradley Vafai (Boston, MA)
Assignee: Metavention, Inc.
A61B18/1492A61B18/18A61N7/022A61B18/24A61B2018/00023A61B2018/0022A61B2018/00404A61B2018/00434A61B2018/00529A61B2018/00577A61B2018/00791A61B2018/00839A61B2018/0212A61B2018/048A61B17/320068A61N5/00A61B17/00A61B17/32A61B18/02A61B18/04A61B18/06A61N7/00A61B17/00234A61B2017/00318A61B18/1815A61B2018/1861A61B18/20A61B2018/00214A61M5/14A61K31/045A61K31/05A61K31/395A61K33/30A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,060,784
App. No.
14/075,949
Granted
Jun 23, 2015
Kind
B2
Abstract

According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.

Claims (44)

1. A hepatic denervation system, comprising:

an outer sheath; and

a radiofrequency (RF) ablation device comprising:

a catheter body having a proximal end and a distal end;

a flexible portion at the distal end of the catheter body configured to facilitate navigation of hepatic arterial vasculature that is highly variable and tortuous;

a pull wire configured to cause deflection of at least a portion of the distal end of the catheter body;

an electrode positioned at a distal tip of the catheter body,

wherein the RF ablation device is configured to be intravascularly advanced through a lumen of the outer sheath to a location of an origin of a common hepatic artery of a subject,

wherein the distal end of the catheter body is configured to be advanced out of a distal end of the outer sheath and positioned within a portion of the common hepatic artery,

wherein the electrode of the RF ablation device is configured to be activated to deliver RF energy sufficient to ablate one or more sympathetic nerves surrounding the common hepatic artery to decrease a blood glucose level within the subject,

wherein the pull wire is configured to cause the electrode to maintain continuous contact with an inner arterial wall of the common hepatic artery at a target site as the common hepatic artery moves in response to diaphragm motion, and

wherein a contact pressure exerted on the wall is between 0.1 g/mm 2 and 10 g/mm 2 .

2. The system of claim 1 , wherein the catheter body of the RF ablation device has a length sufficient to extend from an access point in a femoral or radial artery to the portion of the common hepatic artery.

3. The system of claim 1 , wherein the RF ablation device comprises a bipolar electrode pair.

4. The system of claim 1 , wherein the RF ablation device comprises a thermocouple configured to monitor temperature levels.

5. The system of claim 1 , wherein the distal end of the catheter body comprises an independently controllable bending segment configured to be deflected by the pull wire.

6. The system of claim 1 , wherein a diameter of the electrode is larger than a diameter of the distal end of the catheter body.

7. The system of claim 1 ,

wherein the RF energy configured to be delivered by the electrode at the target site is between 100 J and 1 kJ,

wherein the RF energy has a frequency in the range of 50 kHz to 5 MHz, and

wherein the RF energy is delivered to heat the one or more sympathetic nerves of the hepatic plexus to a temperature of up to 90 degrees Celsius and sufficient to cause ablation of the one or more sympathetic nerves.

8. The system of claim 1 , wherein the outer sheath comprises a guide catheter.

9. The system of claim 1 , wherein the distal end of the catheter body comprises a resiliently-deformable material.

10. A hepatic denervation system, comprising:

a guide catheter; and

an energy delivery device configured to be delivered intravascularly through the guide catheter, the energy delivery device comprising:

a catheter body having a proximal end and a distal end,

wherein the catheter body is configured for percutaneous, intravascular placement through highly variable and tortuous arterial vasculature to a common hepatic artery of a subject;

a flexible portion at the distal end of the catheter body configured to facilitate navigation of the highly variable and tortuous arterial vasculature associated with intravascularly access and insertion within a portion of the common hepatic artery;

a pull wire configured to cause deflection of at least a portion of the distal end of the catheter body; and

an electrode positioned at a distal tip of the catheter body,

wherein the distal end of the catheter body is configured to be intravascularly advanced to a target location within the portion of the common hepatic artery,

wherein the electrode of the catheter body is configured to be activated to deliver energy sufficient to cause denervation of one or more sympathetic nerves associated with the liver to decrease a blood glucose level within the subject,

wherein the pull wire is configured to cause the electrode to maintain continuous contact with an inner arterial wall of the common hepatic artery at the target location as the common hepatic artery moves in response to diaphragm motion, and

wherein a contact pressure exerted on the wall is configured to be between 0.1 g/mm 2 and 100 g/mm 2 .

11. The system of claim 10 , wherein the catheter body comprises a lumen.

12. The system of claim 11 , wherein the catheter body is configured to be delivered over a guide wire.

13. The system of claim 10 , further comprising an outer sheath, and wherein the energy delivery device is configured to be delivered within a lumen of the outer sheath to the target location within the common hepatic artery and is translatable relative to the outer sheath.

14. The device of claim 10 , wherein the catheter body has a length sufficient to extend from an incision in a femoral or radial artery to the target location within the common hepatic artery.

15. The device of claim 10 , wherein the energy configured to be delivered by the electrode at the target location is radiofrequency (RF) energy between 100 J and 1 kJ.

16. The device of claim 10 , wherein the catheter body comprises a bipolar electrode pair.

17. The device of claim 15 ,

wherein the RF energy has a frequency in the range of 50 kHz to 5 MHz, and

wherein the RF energy is delivered to heat the one or more sympathetic nerves to a temperature of up to 90 degrees Celsius and sufficient to cause ablation of the one or more sympathetic nerves.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2023
From: METAVENTION, INC.
To: MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY
Reel/Frame 064987/0161 →
RELEASE OF SECURITY INTEREST Recorded Aug 22, 2023
From: CUSTOMERS BANK (SUCCESSOR IN INTEREST TO SIGNATURE BANK)
To: METAVENTION, INC.
Reel/Frame 064670/0039 →
SECURITY INTEREST Recorded Jan 11, 2023
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 062349/0859 →
SECURITY INTEREST Recorded Oct 31, 2022
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 061602/0249 →
SECURITY INTEREST Recorded Jun 29, 2022
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 060358/0417 →
SECURITY INTEREST Recorded Dec 20, 2021
From: METAVENTION, INC.
To: SIGNATURE BANK
Reel/Frame 058433/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2013
From: AZAMIAN, BOBAK ROBERT; COE, JONATHAN ALLEN; VAFAI, SCOTT BRADLEY
To: METAVENTION, INC.
Reel/Frame 031578/0683 →
Continuity (4)
Continuation 13789509 · Mar 7, 2013
Continuation PCTUS2012068630 · Dec 7, 2012
Provisional Application 61568843 · Dec 9, 2011
Related Publication 20140066922A1 · Mar 6, 2014